Brain tumors can absolutely cause symptoms that look like dementia, and in some cases the resemblance is so convincing that patients receive an Alzheimer’s or frontotemporal dementia diagnosis before anyone suspects a tumor. The cognitive decline from a brain tumor can include memory loss, personality changes, confusion, language difficulties, and impaired judgment. What makes this clinically important is that tumor-caused dementia is sometimes reversible once the tumor is treated, unlike most neurodegenerative diseases.
How Brain Tumors Produce Dementia-Like Symptoms
A tumor growing inside the skull can disrupt cognition through several routes. The most straightforward is direct pressure or infiltration: as a mass expands, it compresses or invades brain tissue responsible for memory, executive function, language, or attention. But a tumor does not need to sit in a “memory center” to cause dementia-like problems. A pituitary adenoma, for instance, can partially block the flow of cerebrospinal fluid and produce a condition called hydrocephalus, where fluid buildup in the ventricles damages white matter pathways. One documented case showed a patient whose global dementia was the initial sign of a pituitary tumor, even though the patient had no visual or hormonal symptoms and no obvious signs of increased pressure in the skull.1Journal of the Neurological Sciences. Dementia and low-pressure hydrocephalus in a patient with pituitary adenoma
Tumors can also disrupt the brain’s functional networks, essentially scrambling communication between regions that need to coordinate for complex thought. Research on patients with frontal gliomas found that tumors altered connectivity within the brain’s default mode network and between the default mode network and the central executive network. These connectivity changes correlated with executive dysfunction, meaning planning, decision-making, and mental flexibility all suffered.2Journal of Neurosurgery. Alteration of default mode network: association with executive dysfunction in frontal glioma patients Separately, researchers found that tumors in the left hemisphere had a disproportionately large effect on this network’s connectivity regardless of tumor size or type, while right-sided tumors did not show the same pattern.3PubMed. Exploratory study of the effect of brain tumors on the default mode network This means a relatively small tumor in the wrong spot can have outsized cognitive consequences.
Which Tumor Types Are Most Often Mistaken for Dementia
Not all brain tumors present this way, but several types are repeat offenders when it comes to mimicking neurodegenerative disease.
Meningiomas are the classic example. These slow-growing tumors arise from the membranes surrounding the brain, and because they grow gradually, the brain adapts for a long time before symptoms become obvious. When symptoms finally appear, they tend to be psychiatric or cognitive rather than the headaches and seizures people associate with brain tumors. A review of meningioma cases found that these tumors can present with mood symptoms, psychosis, memory disturbances, personality changes, and anxiety, and that neuropsychiatric symptoms are sometimes the only manifestation.4PubMed. Meningioma and psychiatric symptoms: An individual patient data analysis A 73-year-old woman with two large meningiomas showed slow progressive memory loss along with decreases in attention, language, visuospatial function, and executive function, a profile that looked clinically identical to Alzheimer’s disease.5Annals of Geriatric Medicine and Research. Huge Intracranial Meningioma Mimicking Alzheimer Dementia
Glioblastomas, the most aggressive primary brain cancer, can also present as dementia. In one case report, a patient’s wife described seven months of cognitive decline, social withdrawal, executive processing errors, visuospatial dysfunction, and memory loss across both short-term and long-term domains. He had begun neglecting basic hygiene, gave short vague answers, and showed decline in all activities of daily living. The clinical picture closely resembled frontotemporal dementia.6International Journal of Case Reports and Images. Glioblastoma multiforme mimicking frontotemporal dementia: A case report A particularly deceptive variant is glioblastoma with a diffuse, widespread growth pattern, which can cause rapidly progressive cognitive decline without producing the kind of obvious mass that stands out on early imaging. One such case remained a diagnostic puzzle for three months as imaging findings evolved.7PubMed Central. Glioblastoma with Gliomatosis Cerebri Growth Pattern Presenting as Rapidly Progressive Dementia
Primary central nervous system lymphoma, a rare brain cancer, deserves special mention because it can present as rapidly progressive dementia. The speed of decline is actually a clue: while Alzheimer’s disease typically unfolds over years, CNS lymphoma can cause severe cognitive deterioration in weeks to months.8PubMed Central. Diagnostic Odyssey: Primary CNS Lymphoma (Lymphoma Cerebri) Presenting as Rapidly Progressive Dementia It is one of several conditions that belong on the list when someone develops dementia symptoms unusually fast.9PubMed Central. Neurocognitive Features Distinguishing Primary Central Nervous System Lymphoma from Other Possible Causes of Rapidly Progressive Dementia
Why Tumors Get Misdiagnosed as Psychiatric or Neurodegenerative Conditions
The overlap between tumor-related cognitive decline and primary psychiatric or neurodegenerative conditions is large enough that misdiagnosis happens more often than you might expect, even in an era when advanced brain imaging is widely available. Tumors involving the frontal and temporal lobes are particularly prone to being misread as depression, psychosis, or dementia, because the symptoms they produce, like mood disturbances, personality changes, and behavioral abnormalities, are hallmarks of those psychiatric and neurological diagnoses.10Progress in Neurology and Psychiatry. Diagnostic Pitfalls: Uncovering Brain Tumors Misinterpreted as Cognitive and Psychiatric Conditions
In some documented cases, patients with brain tumors received long-term treatment for depression before anyone ordered a scan.11PubMed Central. Why in the age of CT scans and MRIs is a brain tumour mistaken for a psychiatric illness? The problem isn’t that clinicians are careless. It’s that the symptoms genuinely do not look neurological at first. A patient who seems withdrawn, apathetic, and forgetful does not immediately scream “brain tumor” the way a patient with seizures or weakness on one side of the body does. The tumor sneaks in under the cover of a more common diagnosis.
Guidelines from the UK’s National Institute for Health and Care Excellence recommend structural imaging to rule out reversible causes of cognitive decline, but they also note that imaging is especially warranted when the pattern of decline is atypical for a standard dementia presentation. Red flags include seizures, signs of raised pressure in the skull, rapid onset, focal neurological symptoms like limb weakness or coordination problems, and cognitive deficits that don’t follow the usual memory-first pattern of Alzheimer’s.12Archives of Biological Psychiatry. Atypical presentation of massive glioblastoma mimicking rapidly progressive dementia The challenge is that slow-growing tumors like meningiomas often produce none of those red flags. Their symptoms creep in so gradually that neither the patient nor their family recognizes the change as abnormal until it is quite advanced.
When Tumor-Related Dementia Can Be Reversed
This is arguably the most important practical takeaway. When the tumor is benign and can be surgically removed, the dementia it caused can dramatically improve or resolve entirely. A case series of three patients with large frontal meningiomas who presented with cognitive impairment as their initial symptom found that all three showed dramatic cognitive improvement after surgical resection and were able to return to normal social functioning.13PubMed Central. Neuroimaging Recommendations in Outpatients With Dementia: Three Cases of Frontal Meningioma Demonstrating Reversible Dementia
Larger studies back this up. In one group of meningioma patients, average scores on a standard cognitive screening test rose from about 20 out of 30 before surgery to about 27 afterward, a jump from “moderate impairment” to “near normal.”14PubMed. Cognitive dysfunction might be improved in association with recovered neuronal viability after intracranial meningioma resection A more recent study looking at patients with frontotemporal meningiomas found statistically significant postoperative improvements across attention, language, memory, visuospatial function, executive function, and psychiatric symptoms.15PubMed Central. Reversibility of cognitive and psychiatric impairments following surgical resection of frontotemporal meningiomas: a predictive factor analysis
The degree of recovery varies. Patients whose cognitive decline has been present for a shorter time tend to recover more fully, which is one reason early detection matters so much. The brain seems to have some capacity to bounce back once the compressing mass is removed, though longer durations of compression may lead to permanent tissue damage that limits recovery. This window of reversibility is what separates tumor-related dementia from the relentless progression of Alzheimer’s, and it is the strongest argument for imaging in any patient with new or unusual cognitive decline.
Cognitive Damage from Brain Metastases
Cancers that start elsewhere in the body and spread to the brain are a separate but related concern. In patients newly diagnosed with brain metastases, cognitive impairment is the rule rather than the exception. One study found that fewer than one in five patients with brain metastases were completely cognitively intact across all tests. Over 80 percent were impaired on at least one measure, and more than half were impaired on three or more. Verbal memory was the most common deficit, followed by attention, executive functioning, and language.16PubMed Central. Cognition in patients with newly diagnosed brain metastasis: profiles and implications
Unlike meningiomas, brain metastases tend to come from aggressive cancers like lung, breast, or melanoma, and they often appear as multiple lesions scattered throughout the brain. The cognitive effects are a combination of the tumors themselves, the surrounding swelling, and the general systemic illness. Treatment with radiation or surgery can help, but the prognosis is usually more guarded than with benign tumors. Still, knowing the extent of cognitive impairment matters for planning care and setting realistic expectations.
Paraneoplastic Syndromes and Dementia at a Distance
A tumor does not even have to be inside the brain to cause dementia-like symptoms. Paraneoplastic limbic encephalitis is a rare condition in which the body’s immune response to a cancer elsewhere in the body attacks the brain’s limbic system, which is critical for memory and emotion. It is characterized by personality changes, irritability, depression, seizures, memory loss, and sometimes full-blown dementia. In about 60 percent of cases, the neurological symptoms appear before the cancer is even diagnosed, typically preceding it by a median of about three and a half months.17PubMed. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
This creates a particularly frustrating diagnostic scenario: a patient develops memory problems and personality changes, clinicians suspect a neurodegenerative disease, and the underlying cancer goes undetected. The antibodies driving the immune attack can sometimes be identified through blood tests, which is why unexplained rapidly progressive dementia, especially in someone younger than the typical Alzheimer’s population, should prompt a broader workup.
When Treatment Itself Causes Cognitive Decline
Even when a brain tumor is successfully treated, the treatment can leave its own cognitive footprint. Radiation therapy directed at the brain carries a well-known risk of late-onset cognitive decline. In one study, patients developed progressive dementia three to twelve months after a course of brain radiation, with brain scans showing enlargement of the ventricles and widespread damage to the white matter that connects different brain regions.18PubMed. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy When chemotherapy was added to radiation, the risk appeared to be compounded.
This is a difficult tradeoff in brain tumor treatment. Radiation may be necessary to control the tumor, but it damages healthy tissue in the process, particularly the white matter tracts and hippocampal regions that are essential for memory and learning. Modern radiation techniques aim to reduce this collateral damage by targeting the tumor more precisely and sparing the hippocampus when possible, though the risk is not fully eliminated.
The cognitive effects of treatment are an especially pressing concern for children who survive brain tumors. A systematic review of long-term outcomes found that pediatric brain tumor survivors commonly experience deficits in IQ, processing speed, working memory, and academic performance, with lasting effects on educational and occupational functioning that persist into adulthood.19PubMed Central. Long-term neurocognitive and behavioral outcomes in survivors of pediatric brain tumors: a systematic review For a child whose brain is still developing, the combination of the tumor itself and the treatments used against it can reshape cognitive trajectories in ways that show up years or decades later.
When a Tumor and True Neurodegeneration Coexist
One complication worth knowing about is that brain tumors and neurodegenerative disease are not mutually exclusive. Researchers examining the brain tissue surrounding glioblastomas found that about 44 percent of samples showed Alzheimer’s-type pathology, including amyloid-beta plaques, tau tangles, or both. The likelihood increased with age.20PubMed Central. Alzheimer-type neuropathological changes in glioblastoma-adjacent cortex This does not necessarily mean the tumor caused the Alzheimer’s pathology. It more likely reflects the fact that brain tumors and Alzheimer’s disease both become more common with age, so they can overlap in the same patient.
The practical implication is that removing a tumor or treating it may not resolve all of a patient’s cognitive symptoms if an underlying neurodegenerative process is also underway. Families hoping for full cognitive recovery after brain tumor surgery in an elderly patient should be prepared for the possibility that some degree of decline was not caused by the tumor. Distinguishing how much of the cognitive picture belongs to the tumor and how much to coexisting neurodegeneration is one of the genuinely hard problems in clinical neurology.
Red Flags That Suggest a Tumor Rather Than Standard Dementia
No single symptom reliably distinguishes tumor-related cognitive decline from neurodegenerative dementia, but certain patterns should raise suspicion. Clinicians and families should pay attention to:
- Speed of onset: Most neurodegenerative dementias progress over years. Cognitive decline that develops or accelerates over weeks to months is more consistent with a tumor, infection, or autoimmune process.
- Atypical symptom pattern: If early symptoms are dominated by personality changes, behavioral disinhibition, or visuospatial problems rather than the gradual memory loss typical of early Alzheimer’s, the clinical picture is less straightforward.
- Focal neurological signs: Weakness on one side of the body, new-onset seizures, coordination problems, vision changes, or persistent headaches, especially worse in the morning, suggest a structural cause.
- Younger age: Neurodegenerative dementia in someone under 65 is less common and warrants a more thorough investigation, including imaging.
- Psychiatric symptoms that don’t respond to treatment: Depression or psychosis that fails to improve with appropriate medication could be masking an underlying lesion.
None of these features guarantee a tumor is present, but any of them should lower the threshold for ordering brain imaging. The cost of a missed tumor, given that some tumor-related dementia is reversible, is much higher than the cost of a scan that comes back normal.